Frentizole, an FDA-approved immunosuppressant, is a Abeta-ABAD (binding alcohol dehydrogenase) interaction inhibitor with an IC50 value of 200 µM. Frentizole is used in studies of diseases related to rheumatoid arthritis and systemic lupus erythematosus[1][2][3].
Molecular Weight:
299.35
Purity:
99.21
CAS Number:
[26130-02-9]
Formula:
C15H13N3O2S
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted